References
- van den Berg-Vos RM, Visser J, Franssen H, de Visser JM, de Jong JMBV, Kalmijn S, et al. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain. 2003;136:1026–47.
- Gonzalez H, Ottervald J, Nilsson KC, Niclas Sjögrend N, Miliotise T, von Bahre H, et al. Identification of novel candidate protein biomarkers for the post-polio syndrome: implications for diagnosis, neurodegeneration and neuroinflammation. J Proteomics. 2009;71:670–81.
- Corrado L, Ratti A, Gellera C, Buratti E, Castellotti B, Carlomagno Y, et al. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat. 2009;30:688–94.
- del Bo R, Ghezzi S, Corti S, Pandolfo M, Ranieria M, Santoro D. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur J Neurol. 2009;16:727–32.
- Williams KL, Durnall JC, Thoeng AD, Warraich ST, Nicholson GA, Blair IP. A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred. J Neurol Neurosurg Psychiatry. 2009;80:1286–8.
- Conforti FL, Sproviero W, Simone IL, Mazze R, Valentino P, Ungaro C, et al. TARDBP gene mutations in southern Italian patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:587–8.
- Kühnlein P, Sperfeld AD, Vanmassenhove B, van Deerlin V, Lee V, Trojanowski JQ, et al. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol. 2008;65:1185–9.
- van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409–16.
- Rekand T, Karlsen T, Langeland N, Aarli JA. Long-Term Follow-Up of Patients with Non-Paralytic Poliomyelitis. Arch Phys Med Rehabil. 2002;83:533–7.
- Scarisbrick IA, Blaber SI, Tingling JT, Rodriguez M, Blaber M, Christophi GP. Potential scope of action of tissue kallikreins in CNS immune-mediated disease J Neuroimmunol. 2006;178:167–76.
- Menenez-Gonzalez M, Castro-Santos P, Suarez A, Calatayud MT, Perez-Pinera P, Martinez M, et al. Value of measuring plasmatic levels of neurosin in the diagnosis of Alzheimer’s disease. J Alzheimers Dis. 2008;1:59–67.
- Hebb AL, Bhan V, Wishart AD, Moore CS, Robertson GS. Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis. Curr Drug Discov Technol. 2010;2:137–40.